Gary S. Friedman

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers”.

Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers

Kidney International Reports(2025)10.1016/j.ekir.2025.01.035

N/A

0.292DataRank · unranked

6 citations

Gary S. Friedman, Xavier Benain, Nunzio Camerlingo, Stefan Sultana, Shiran Shapira +3 more

Sa1750 - The Effect of Tofacitinib on Serum Lipids and Cardiovascular Safety in Patients with Ulcerative Colitis - Results from the Tofacitinib Ulcerative Colitis Clinical Program

Gastroenterology(2018)10.1016/s0016-5085(18)31574-9

N/A

0.104DataRank · unranked

1 citations

Pam R. Taub, Brian G. Feagan, Alessandro Armuzzi, Gary S. Friedman, Michele Moscariello +8 more